Nefropatia da analgesici (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Nefropatia da analgesici" in Italian language version.

refsWebsite

Global rank Italian rank

33nih.gov

4^th place

9^th place

19doi.org

2^nd place

7^th place

9archive.org

6^th place

8^th place

9oadoi.org

799^th place

22^nd place

4oxfordjournals.org

1,389^th place

732^nd place

1asnjournals.org

low place

1nejm.org

2,374^th place

1,283^rd place

archive.org

McLaughlin JK, Lipworth L, Chow WH, Blot WJ, Analgesic use and chronic renal failure: a critical review of the epidemiologic literature, in Kidney Int., vol. 54, n. 3, settembre 1998, pp. 679–86, DOI:10.1046/j.1523-1755.1998.00043.x, PMID 9734593.
A. Schwarz, L. Preuschof; D. Zellner, Incidence of analgesic nephropathy in Berlin since 1983., in Nephrol Dial Transplant, vol. 14, n. 1, gennaio 1999, pp. 109-12, PMID 10052487.
Feinstein AR, Heinemann LA, Curhan GC, et al., Relationship between nonphenacetin combined analgesics and nephropathy: a review. Ad Hoc Committee of the International Study Group on Analgesics and Nephropathy, in Kidney Int., vol. 58, n. 6, dicembre 2000, pp. 2259–64, DOI:10.1046/j.1523-1755.2000.00410.x, PMID 11115060.
Bach PH, Hardy TL, Relevance of animal models to analgesic-associated renal papillary necrosis in humans, in Kidney Int., vol. 28, n. 4, ottobre 1985, pp. 605–13, DOI:10.1038/ki.1985.172, PMID 3910912.
Murray TG, Goldberg M, Analgesic-associated nephropathy in the U.S.A.: epidemiologic, clinical and pathogenetic features, in Kidney Int., vol. 13, n. 1, gennaio 1978, pp. 64–71, DOI:10.1038/ki.1978.9, PMID 713270.
Nanra RS, Stuart-Taylor J, de Leon AH, White KH, Analgesic nephropathy: etiology, clinical syndrome, and clinicopathologic correlations in Australia, in Kidney Int., vol. 13, n. 1, gennaio 1978, pp. 79–92, DOI:10.1038/ki.1978.11, PMID 362034.
Elseviers MM, De Schepper A, Corthouts R, et al., High diagnostic performance of CT scan for analgesic nephropathy in patients with incipient to severe renal failure, in Kidney Int., vol. 48, n. 4, ottobre 1995, pp. 1316–23, DOI:10.1038/ki.1995.416, PMID 8569094.
Maisonneuve P, Agodoa L, Gellert R, et al., Distribution of primary renal diseases leading to end-stage renal failure in the United States, Europe, and Australia/New Zealand: results from an international comparative study, in Am. J. Kidney Dis., vol. 35, n. 1, gennaio 2000, pp. 157–65, DOI:10.1016/S0272-6386(00)70316-7, PMID 10620560.
Blohmé I, Johansson S, Renal pelvic neoplasms and atypical urothelium in patients with end-stage analgesic nephropathy, in Kidney Int., vol. 20, n. 5, novembre 1981, pp. 671–5, DOI:10.1038/ki.1981.192, PMID 7045494.

asnjournals.org

jasn.asnjournals.org

Michielsen P, de Schepper P, Trends of analgesic nephropathy in two high-endemic regions with different legislation, in J. Am. Soc. Nephrol., vol. 12, n. 3, marzo 2001, pp. 550–6, PMID 11181803.

doi.org

dx.doi.org

McLaughlin JK, Lipworth L, Chow WH, Blot WJ, Analgesic use and chronic renal failure: a critical review of the epidemiologic literature, in Kidney Int., vol. 54, n. 3, settembre 1998, pp. 679–86, DOI:10.1046/j.1523-1755.1998.00043.x, PMID 9734593.
ME. De Broe, MM. Elseviers, Analgesic nephropathy., in N Engl J Med, vol. 338, n. 7, febbraio 1998, pp. 446-52, DOI:10.1056/NEJM199802123380707, PMID 9459649.
P. Michielsen, In memoriam 'analgesic nephropathy' (circa 1972-2006)., in Nephrol Dial Transplant, vol. 22, n. 4, aprile 2007, pp. 999-1001, DOI:10.1093/ndt/gfl797, PMID 17213226.
FJ. van der Woude, LA. Heinemann; H. Graf; M. Lewis; S. Moehner; A. Assmann; D. Kühl-Habich, Analgesics use and ESRD in younger age: a case-control study., in BMC Nephrol, vol. 8, 2007, p. 15, DOI:10.1186/1471-2369-8-15, PMID 18053232.
LA. Heinemann, E. Garbe; M. Lewis; F. van der Woude; H. Graf, Case-control study on analgesics and nephropathy (SAN): protocol., in BMC Nephrol, vol. 6, 2005, p. 9, DOI:10.1186/1471-2369-6-9, PMID 16086834.
Mihatsch MJ, Khanlari B, Brunner FP, Obituary to analgesic nephropathy--an autopsy study, in Nephrol. Dial. Transplant., vol. 21, n. 11, novembre 2006, pp. 3139–45, DOI:10.1093/ndt/gfl390, PMID 16891638.
Feinstein AR, Heinemann LA, Curhan GC, et al., Relationship between nonphenacetin combined analgesics and nephropathy: a review. Ad Hoc Committee of the International Study Group on Analgesics and Nephropathy, in Kidney Int., vol. 58, n. 6, dicembre 2000, pp. 2259–64, DOI:10.1046/j.1523-1755.2000.00410.x, PMID 11115060.
D. Steinert, C. Küper; H. Bartels; FX. Beck; W. Neuhofer, PGE2 potentiates tonicity-induced COX-2 expression in renal medullary cells in a positive feedback loop involving EP2-cAMP-PKA signaling., in Am J Physiol Cell Physiol, vol. 296, n. 1, gennaio 2009, pp. C75-87, DOI:10.1152/ajpcell.00024.2008, PMID 19005164.
RC. Harris, MD. Breyer, Update on cyclooxygenase-2 inhibitors., in Clin J Am Soc Nephrol, vol. 1, n. 2, marzo 2006, pp. 236-45, DOI:10.2215/CJN.00890805, PMID 17699212.
V. Schneider, LE. Lévesque; B. Zhang; T. Hutchinson; JM. Brophy, Association of selective and conventional nonsteroidal antiinflammatory drugs with acute renal failure: A population-based, nested case-control analysis., in Am J Epidemiol, vol. 164, n. 9, novembre 2006, pp. 881-9, DOI:10.1093/aje/kwj331, PMID 17005625.
Bach PH, Hardy TL, Relevance of animal models to analgesic-associated renal papillary necrosis in humans, in Kidney Int., vol. 28, n. 4, ottobre 1985, pp. 605–13, DOI:10.1038/ki.1985.172, PMID 3910912.
Mohandas J, Duggin GG, Horvath JS, Tiller DJ, Metabolic oxidation of acetaminophen (paracetamol) mediated by cytochrome P-450 mixed-function oxidase and prostaglandin endoperoxide synthetase in rabbit kidney, in Toxicol. Appl. Pharmacol., vol. 61, n. 2, novembre 1981, pp. 252–9, DOI:10.1016/0041-008X(81)90415-4, PMID 6798713.
Duggin GG, Combination analgesic-induced kidney disease: the Australian experience, in Am. J. Kidney Dis., vol. 28, 1 Suppl 1, luglio 1996, pp. S39–47, DOI:10.1016/S0272-6386(96)90568-5, PMID 8669429.
Murray TG, Goldberg M, Analgesic-associated nephropathy in the U.S.A.: epidemiologic, clinical and pathogenetic features, in Kidney Int., vol. 13, n. 1, gennaio 1978, pp. 64–71, DOI:10.1038/ki.1978.9, PMID 713270.
Nanra RS, Stuart-Taylor J, de Leon AH, White KH, Analgesic nephropathy: etiology, clinical syndrome, and clinicopathologic correlations in Australia, in Kidney Int., vol. 13, n. 1, gennaio 1978, pp. 79–92, DOI:10.1038/ki.1978.11, PMID 362034.
de Broe ME, Elseviers MM, Analgesic nephropathy, in N. Engl. J. Med., vol. 338, n. 7, febbraio 1998, pp. 446–52, DOI:10.1056/NEJM199802123380707, PMID 9459649.
Elseviers MM, De Schepper A, Corthouts R, et al., High diagnostic performance of CT scan for analgesic nephropathy in patients with incipient to severe renal failure, in Kidney Int., vol. 48, n. 4, ottobre 1995, pp. 1316–23, DOI:10.1038/ki.1995.416, PMID 8569094.
Maisonneuve P, Agodoa L, Gellert R, et al., Distribution of primary renal diseases leading to end-stage renal failure in the United States, Europe, and Australia/New Zealand: results from an international comparative study, in Am. J. Kidney Dis., vol. 35, n. 1, gennaio 2000, pp. 157–65, DOI:10.1016/S0272-6386(00)70316-7, PMID 10620560.
Blohmé I, Johansson S, Renal pelvic neoplasms and atypical urothelium in patients with end-stage analgesic nephropathy, in Kidney Int., vol. 20, n. 5, novembre 1981, pp. 671–5, DOI:10.1038/ki.1981.192, PMID 7045494.

nejm.org

content.nejm.org

de Broe ME, Elseviers MM, Analgesic nephropathy, in N. Engl. J. Med., vol. 338, n. 7, febbraio 1998, pp. 446–52, DOI:10.1056/NEJM199802123380707, PMID 9459649.

nih.gov

ncbi.nlm.nih.gov

McLaughlin JK, Lipworth L, Chow WH, Blot WJ, Analgesic use and chronic renal failure: a critical review of the epidemiologic literature, in Kidney Int., vol. 54, n. 3, settembre 1998, pp. 679–86, DOI:10.1046/j.1523-1755.1998.00043.x, PMID 9734593.
(DE) Spühler O, Zollinger HU, Die chronisch-interstitielle Nephritis., in Z Klin Med, vol. 151, n. 1, 1953, pp. 1–50, PMID 13137299.
Mihatsch MJ, Khanlari B, Brunner FP. Obituary to analgesic nephropathy--an autopsy study. Nephrol Dial Transplant. 2006 Nov;21(11):3139-45. Epub 2006 Aug 5. PubMed PMID 16891638.
Brunner FP, Selwood NH, End-stage renal failure due to analgesic nephropathy, its changing pattern and cardiovascular mortality. EDTA-ERA Registry Committee, in Nephrol. Dial. Transplant., vol. 9, n. 10, 1994, pp. 1371–6, PMID 7816247.
Mihatsch MJ, Khanlari B, Brunner FP. Obituary to analgesic nephropathy--an autopsy study. Nephrol Dial Transplant. 2006 Nov;21(11):3139-45. Epub 2006 Aug 5.PubMed PMID 16891638.
Elseviers MM, de Broe ME, Analgesic nephropathy in Belgium is related to the sales of particular analgesic mixtures, in Nephrol. Dial. Transplant., vol. 9, n. 1, 1994, pp. 41–6, PMID 8177475.
Noels LM, Elseviers MM, de Broe ME, Impact of legislative measures on the sales of analgesics and the subsequent prevalence of analgesic nephropathy: a comparative study in France, Sweden and Belgium, in Nephrol. Dial. Transplant., vol. 10, n. 2, 1995, pp. 167–74, PMID 7753450.
Michielsen P, de Schepper P, Trends of analgesic nephropathy in two high-endemic regions with different legislation, in J. Am. Soc. Nephrol., vol. 12, n. 3, marzo 2001, pp. 550–6, PMID 11181803.
ME. De Broe, MM. Elseviers, Analgesic nephropathy., in N Engl J Med, vol. 338, n. 7, febbraio 1998, pp. 446-52, DOI:10.1056/NEJM199802123380707, PMID 9459649.
MM. Elseviers, ME. De Broe, Analgesic nephropathy: is it caused by multi-analgesic abuse or single substance use?, in Drug Saf, vol. 20, n. 1, gennaio 1999, pp. 15-24, PMID 9935274.
PH. Bach, WO. Berndt; E. Delzell; U. Dubach; WF. Finn; JM. Fox; R. Hess; P. Michielsen; DP. Sandler; B. Trump; G. Williams, A safety assessment of fixed combinations of acetaminophen and acetylsalicylic acid, coformulated with caffeine., in Ren Fail, vol. 20, n. 6, novembre 1998, pp. 749-62, PMID 9834974.
P. Michielsen, In memoriam 'analgesic nephropathy' (circa 1972-2006)., in Nephrol Dial Transplant, vol. 22, n. 4, aprile 2007, pp. 999-1001, DOI:10.1093/ndt/gfl797, PMID 17213226.
A. Schwarz, L. Preuschof; D. Zellner, Incidence of analgesic nephropathy in Berlin since 1983., in Nephrol Dial Transplant, vol. 14, n. 1, gennaio 1999, pp. 109-12, PMID 10052487.
FJ. van der Woude, LA. Heinemann; H. Graf; M. Lewis; S. Moehner; A. Assmann; D. Kühl-Habich, Analgesics use and ESRD in younger age: a case-control study., in BMC Nephrol, vol. 8, 2007, p. 15, DOI:10.1186/1471-2369-8-15, PMID 18053232.
LA. Heinemann, E. Garbe; M. Lewis; F. van der Woude; H. Graf, Case-control study on analgesics and nephropathy (SAN): protocol., in BMC Nephrol, vol. 6, 2005, p. 9, DOI:10.1186/1471-2369-6-9, PMID 16086834.
Mihatsch MJ, Hofer HO, Gudat F, Knüsli C, Torhorst J, Zollinger HU, Capillary sclerosis of the urinary tract and analgesic nephropathy, in Clin. Nephrol., vol. 20, n. 6, dicembre 1983, pp. 285–301, PMID 6641031.
Mihatsch MJ, Khanlari B, Brunner FP, Obituary to analgesic nephropathy--an autopsy study, in Nephrol. Dial. Transplant., vol. 21, n. 11, novembre 2006, pp. 3139–45, DOI:10.1093/ndt/gfl390, PMID 16891638.
Feinstein AR, Heinemann LA, Curhan GC, et al., Relationship between nonphenacetin combined analgesics and nephropathy: a review. Ad Hoc Committee of the International Study Group on Analgesics and Nephropathy, in Kidney Int., vol. 58, n. 6, dicembre 2000, pp. 2259–64, DOI:10.1046/j.1523-1755.2000.00410.x, PMID 11115060.
D. Steinert, C. Küper; H. Bartels; FX. Beck; W. Neuhofer, PGE2 potentiates tonicity-induced COX-2 expression in renal medullary cells in a positive feedback loop involving EP2-cAMP-PKA signaling., in Am J Physiol Cell Physiol, vol. 296, n. 1, gennaio 2009, pp. C75-87, DOI:10.1152/ajpcell.00024.2008, PMID 19005164.
RC. Harris, MD. Breyer, Update on cyclooxygenase-2 inhibitors., in Clin J Am Soc Nephrol, vol. 1, n. 2, marzo 2006, pp. 236-45, DOI:10.2215/CJN.00890805, PMID 17699212.
J. LeLorier, C. Bombardier; E. Burgess; L. Moist; N. Wright; P. Cartier; V. Huckell; R. Hunt; T. Nawar; S. Tobe, Practical considerations for the use of nonsteroidal anti-inflammatory drugs and cyclo-oxygenase-2 inhibitors in hypertension and kidney disease., in Can J Cardiol, vol. 18, n. 12, dicembre 2002, pp. 1301-8, PMID 12518182.
AN. DeMaria, MR. Weir, Coxibs--beyond the GI tract: renal and cardiovascular issues., in J Pain Symptom Manage, vol. 25, 2 Suppl, febbraio 2003, pp. S41-9, PMID 12604156.
V. Schneider, LE. Lévesque; B. Zhang; T. Hutchinson; JM. Brophy, Association of selective and conventional nonsteroidal antiinflammatory drugs with acute renal failure: A population-based, nested case-control analysis., in Am J Epidemiol, vol. 164, n. 9, novembre 2006, pp. 881-9, DOI:10.1093/aje/kwj331, PMID 17005625.
Bach PH, Hardy TL, Relevance of animal models to analgesic-associated renal papillary necrosis in humans, in Kidney Int., vol. 28, n. 4, ottobre 1985, pp. 605–13, DOI:10.1038/ki.1985.172, PMID 3910912.
Mohandas J, Duggin GG, Horvath JS, Tiller DJ, Metabolic oxidation of acetaminophen (paracetamol) mediated by cytochrome P-450 mixed-function oxidase and prostaglandin endoperoxide synthetase in rabbit kidney, in Toxicol. Appl. Pharmacol., vol. 61, n. 2, novembre 1981, pp. 252–9, DOI:10.1016/0041-008X(81)90415-4, PMID 6798713.
Duggin GG, Combination analgesic-induced kidney disease: the Australian experience, in Am. J. Kidney Dis., vol. 28, 1 Suppl 1, luglio 1996, pp. S39–47, DOI:10.1016/S0272-6386(96)90568-5, PMID 8669429.
Murray TG, Goldberg M, Analgesic-associated nephropathy in the U.S.A.: epidemiologic, clinical and pathogenetic features, in Kidney Int., vol. 13, n. 1, gennaio 1978, pp. 64–71, DOI:10.1038/ki.1978.9, PMID 713270.
Nanra RS, Stuart-Taylor J, de Leon AH, White KH, Analgesic nephropathy: etiology, clinical syndrome, and clinicopathologic correlations in Australia, in Kidney Int., vol. 13, n. 1, gennaio 1978, pp. 79–92, DOI:10.1038/ki.1978.11, PMID 362034.
de Broe ME, Elseviers MM, Analgesic nephropathy, in N. Engl. J. Med., vol. 338, n. 7, febbraio 1998, pp. 446–52, DOI:10.1056/NEJM199802123380707, PMID 9459649.
Elseviers MM, De Schepper A, Corthouts R, et al., High diagnostic performance of CT scan for analgesic nephropathy in patients with incipient to severe renal failure, in Kidney Int., vol. 48, n. 4, ottobre 1995, pp. 1316–23, DOI:10.1038/ki.1995.416, PMID 8569094.
Maisonneuve P, Agodoa L, Gellert R, et al., Distribution of primary renal diseases leading to end-stage renal failure in the United States, Europe, and Australia/New Zealand: results from an international comparative study, in Am. J. Kidney Dis., vol. 35, n. 1, gennaio 2000, pp. 157–65, DOI:10.1016/S0272-6386(00)70316-7, PMID 10620560.
Linton AL, Renal disease due to analgesics. I. Recognition of the problem of analgesic nephropathy, in Can Med Assoc J, vol. 107, n. 8, ottobre 1972, pp. 749–51, PMC 1941002, PMID 4638849.
Blohmé I, Johansson S, Renal pelvic neoplasms and atypical urothelium in patients with end-stage analgesic nephropathy, in Kidney Int., vol. 20, n. 5, novembre 1981, pp. 671–5, DOI:10.1038/ki.1981.192, PMID 7045494.

oadoi.org

ME. De Broe, MM. Elseviers, Analgesic nephropathy., in N Engl J Med, vol. 338, n. 7, febbraio 1998, pp. 446-52, DOI:10.1056/NEJM199802123380707, PMID 9459649.
P. Michielsen, In memoriam 'analgesic nephropathy' (circa 1972-2006)., in Nephrol Dial Transplant, vol. 22, n. 4, aprile 2007, pp. 999-1001, DOI:10.1093/ndt/gfl797, PMID 17213226.
FJ. van der Woude, LA. Heinemann; H. Graf; M. Lewis; S. Moehner; A. Assmann; D. Kühl-Habich, Analgesics use and ESRD in younger age: a case-control study., in BMC Nephrol, vol. 8, 2007, p. 15, DOI:10.1186/1471-2369-8-15, PMID 18053232.
LA. Heinemann, E. Garbe; M. Lewis; F. van der Woude; H. Graf, Case-control study on analgesics and nephropathy (SAN): protocol., in BMC Nephrol, vol. 6, 2005, p. 9, DOI:10.1186/1471-2369-6-9, PMID 16086834.
D. Steinert, C. Küper; H. Bartels; FX. Beck; W. Neuhofer, PGE2 potentiates tonicity-induced COX-2 expression in renal medullary cells in a positive feedback loop involving EP2-cAMP-PKA signaling., in Am J Physiol Cell Physiol, vol. 296, n. 1, gennaio 2009, pp. C75-87, DOI:10.1152/ajpcell.00024.2008, PMID 19005164.
RC. Harris, MD. Breyer, Update on cyclooxygenase-2 inhibitors., in Clin J Am Soc Nephrol, vol. 1, n. 2, marzo 2006, pp. 236-45, DOI:10.2215/CJN.00890805, PMID 17699212.
V. Schneider, LE. Lévesque; B. Zhang; T. Hutchinson; JM. Brophy, Association of selective and conventional nonsteroidal antiinflammatory drugs with acute renal failure: A population-based, nested case-control analysis., in Am J Epidemiol, vol. 164, n. 9, novembre 2006, pp. 881-9, DOI:10.1093/aje/kwj331, PMID 17005625.
Mohandas J, Duggin GG, Horvath JS, Tiller DJ, Metabolic oxidation of acetaminophen (paracetamol) mediated by cytochrome P-450 mixed-function oxidase and prostaglandin endoperoxide synthetase in rabbit kidney, in Toxicol. Appl. Pharmacol., vol. 61, n. 2, novembre 1981, pp. 252–9, DOI:10.1016/0041-008X(81)90415-4, PMID 6798713.
Duggin GG, Combination analgesic-induced kidney disease: the Australian experience, in Am. J. Kidney Dis., vol. 28, 1 Suppl 1, luglio 1996, pp. S39–47, DOI:10.1016/S0272-6386(96)90568-5, PMID 8669429.

oxfordjournals.org

ndt.oxfordjournals.org

Brunner FP, Selwood NH, End-stage renal failure due to analgesic nephropathy, its changing pattern and cardiovascular mortality. EDTA-ERA Registry Committee, in Nephrol. Dial. Transplant., vol. 9, n. 10, 1994, pp. 1371–6, PMID 7816247.
Elseviers MM, de Broe ME, Analgesic nephropathy in Belgium is related to the sales of particular analgesic mixtures, in Nephrol. Dial. Transplant., vol. 9, n. 1, 1994, pp. 41–6, PMID 8177475.
Noels LM, Elseviers MM, de Broe ME, Impact of legislative measures on the sales of analgesics and the subsequent prevalence of analgesic nephropathy: a comparative study in France, Sweden and Belgium, in Nephrol. Dial. Transplant., vol. 10, n. 2, 1995, pp. 167–74, PMID 7753450.
Mihatsch MJ, Khanlari B, Brunner FP, Obituary to analgesic nephropathy--an autopsy study, in Nephrol. Dial. Transplant., vol. 21, n. 11, novembre 2006, pp. 3139–45, DOI:10.1093/ndt/gfl390, PMID 16891638.